|
CA1270488A
(en)
|
1983-09-26 |
1990-06-19 |
John M. Schaus |
Pyrazole-ring alkylated pyrazoloquinolines and intermediates
|
|
GB8828669D0
(en)
|
1988-12-08 |
1989-01-11 |
Lilly Industries Ltd |
Organic compounds
|
|
DE69430373T2
(de)
|
1993-08-06 |
2002-12-12 |
Smithkline Beecham S.P.A., Baranzate Di Bollate |
Hydroisochinolinderivate
|
|
US5688808A
(en)
|
1994-12-22 |
1997-11-18 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
|
JP4498602B2
(ja)
|
1998-03-10 |
2010-07-07 |
リサーチ・トライアングル・インスティチュート |
新規なオピエート化合物、その調製法及び使用法
|
|
US6166013A
(en)
|
1998-07-30 |
2000-12-26 |
Abbott Laboratories |
Glucocortiocoid-selective agents
|
|
AU2620600A
(en)
|
1999-01-21 |
2000-08-07 |
Steroidogenesis Inhibitors International |
Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
|
|
GB9911053D0
(en)
|
1999-05-12 |
1999-07-14 |
Pharmacia & Upjohn Spa |
4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
|
|
GB0010683D0
(en)
|
2000-05-03 |
2000-06-28 |
Univ Bristol |
Cancer therapy
|
|
US6583180B2
(en)
|
2001-02-14 |
2003-06-24 |
Abbott Laboratories |
Glucocorticoid receptor modulators
|
|
WO2002069995A2
(en)
|
2001-02-16 |
2002-09-12 |
Medical College Of Georgia Research Institute, Inc. |
Use of trail and antiprogestins for treating cancer
|
|
AU2002355929A1
(en)
|
2001-07-17 |
2003-03-03 |
Smithkline Beecham Corporation |
Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same
|
|
CN1547473A
(zh)
|
2001-07-23 |
2004-11-17 |
�Ƹ��� |
预防由抗精神病药物引起的体重增加的方法
|
|
ATE411013T1
(de)
|
2001-08-31 |
2008-10-15 |
Corcept Therapeutics Inc |
Verfahren zur hemmung der verschlechterung der kognitiven leistungsfähigkeit bei erwachsenen mit down-syndrom
|
|
CA2473886C
(en)
|
2002-01-22 |
2012-08-21 |
The Regents Of The University Of California |
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
EP1534299A4
(en)
|
2002-07-02 |
2007-04-11 |
Corcept Therapeutics Inc |
METHOD FOR TREATING PSYCHOSIS IN CONNECTION WITH INTERFERON-ALPHA THERAPY
|
|
AU2003270783C1
(en)
|
2002-09-20 |
2010-05-20 |
Merck Sharp & Dohme Corp. |
Octahydro-2-H-naphtho[1,2-F] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
|
AU2004208842B2
(en)
|
2003-02-04 |
2009-05-28 |
Corcept Therapeutics, Inc. |
Antiglucocorticoids for the treatment of postpartum psychosis
|
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
EP1660081A1
(en)
|
2003-09-03 |
2006-05-31 |
Wyeth |
Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and pharmaceutical compositions containing the same
|
|
CA2552419C
(en)
|
2004-01-09 |
2013-04-23 |
Corcept Therapeutics, Inc. |
Azadecalin glucocorticoid receptor modulators
|
|
EP1723174A1
(en)
|
2004-02-26 |
2006-11-22 |
The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health |
A novel modulator of glucocorticoid receptor activities
|
|
JP4931794B2
(ja)
|
2004-03-09 |
2012-05-16 |
コーセプト セラピューティクス, インコーポレイテッド |
縮合環アザデカリン糖質コルチコイド受容体モジュレーター
|
|
US7576076B2
(en)
|
2004-07-02 |
2009-08-18 |
Corcept Therapeutics, Inc. |
Modified pyrimidine glucocorticoid receptor modulators
|
|
ES2493466T3
(es)
|
2005-05-12 |
2014-09-11 |
Abbvie Bahamas Ltd. |
Promotores de la apoptosis
|
|
US7790745B2
(en)
|
2005-10-21 |
2010-09-07 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline LXR Modulators
|
|
US7640389B2
(en)
|
2006-02-28 |
2009-12-29 |
Freescale Semiconductor, Inc. |
Non-volatile memory having a multiple block erase mode and method therefor
|
|
EP1932843A1
(en)
|
2006-12-14 |
2008-06-18 |
sanofi-aventis |
Sulfonyl-phenyl-2H-(1,2,4) oxadiazole-5-one derivatives, processes for their preparation and their use as pharmaceuticals
|
|
WO2009064738A2
(en)
|
2007-11-12 |
2009-05-22 |
Bipar Sciences, Inc. |
Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
|
|
US20120022121A1
(en)
|
2007-11-29 |
2012-01-26 |
Dalton James T |
Indoles, derivatives and analogs thereof and uses therefor
|
|
US20090156672A1
(en)
|
2007-12-17 |
2009-06-18 |
Northwestern University |
Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities
|
|
US8003689B2
(en)
|
2008-06-20 |
2011-08-23 |
Gtx, Inc. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
|
US20110166115A1
(en)
|
2008-07-01 |
2011-07-07 |
Corcept Therapeutics, Inc. |
Use of mifepristone for the treatment of amyotrophic lateral sclerosis
|
|
US20100135956A1
(en)
|
2008-11-21 |
2010-06-03 |
Auspex Pharmaceuticals, Inc. |
Steroid modulators of progesterone receptor and/or glucocorticoid receptor
|
|
AU2010247766B2
(en)
|
2009-05-12 |
2015-05-21 |
Corcept Therapeutics, Inc. |
Solid forms and process for preparing
|
|
US9068185B2
(en)
|
2010-03-12 |
2015-06-30 |
Sarepta Therapeutics, Inc. |
Antisense modulation of nuclear hormone receptors
|
|
US8710035B2
(en)
|
2010-03-24 |
2014-04-29 |
The University Of Chicago |
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
|
|
BR112013004322A2
(pt)
|
2010-08-27 |
2016-06-21 |
Corcept Therapeutics Inc |
moduladores de azadecalin fundidos com piridil-aminas
|
|
US8658128B2
(en)
|
2011-02-03 |
2014-02-25 |
Pop Test Cortisol Llc |
System and method for diagnosis and treatment
|
|
US9314473B2
(en)
|
2011-02-03 |
2016-04-19 |
Pop Test Oncology Limited Liability Company |
System and method for diagnosis and treatment
|
|
CN103596431B
(zh)
|
2011-03-18 |
2016-06-22 |
科赛普特治疗公司 |
嘧啶环己基糖皮质激素受体调节剂
|
|
WO2013039916A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services |
Compositions for and methods of treatment and enhanced detection of non-pituitary tumors
|
|
MX370976B
(es)
|
2011-11-11 |
2020-01-10 |
Gilead Apollo Llc |
Inhibidores de acetil coa carboxilasa (acc) y usos de los mismos.
|
|
ES2991315T3
(es)
|
2012-02-24 |
2024-12-03 |
Univ Chicago |
Métodos y composiciones relacionados con el antagonismo del receptor de glucocorticoides y con el cáncer de próstata
|
|
WO2013130420A1
(en)
|
2012-02-27 |
2013-09-06 |
Corcept Therapeutics, Inc. |
Phenyl heterocycloalkyl glucocorticoid receptor modulators
|
|
NZ701469A
(en)
*
|
2012-05-25 |
2017-06-30 |
Corcept Therapeutics Inc |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
PT2861611T
(pt)
|
2012-05-25 |
2016-10-11 |
Janssen Sciences Ireland Uc |
Nucleósidos de espirooxetano de uracilo
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
ES2943542T3
(es)
|
2013-11-25 |
2023-06-14 |
Corcept Therapeutics Inc |
Moduladores del receptor de glucocorticoides de azadecalina condensada con octahidro
|
|
US10532150B2
(en)
|
2014-07-21 |
2020-01-14 |
Medtronic Minimed, Inc. |
Smart connection interface
|
|
EP3006453A1
(en)
|
2014-10-08 |
2016-04-13 |
Cosmo Technologies Ltd. |
17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors
|
|
EP3233916A4
(en)
|
2014-12-19 |
2018-06-06 |
Alder Biopharmaceuticals, Inc. |
Humanized anti-acth antibodies and use thereof
|
|
JP6821582B2
(ja)
|
2015-03-02 |
2021-01-27 |
コーセプト セラピューティクス, インコーポレイテッド |
Acth分泌腫瘍を処置するための糖質コルチコイドレセプターアンタゴニストおよびソマトスタチンアナログの使用
|
|
US20180064679A1
(en)
|
2015-03-05 |
2018-03-08 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of glucocorticoid receptor
|
|
US9598459B2
(en)
|
2015-08-03 |
2017-03-21 |
Pop Test Oncology Llc |
Pharmaceutical compositions and methods
|
|
MX383318B
(es)
|
2015-08-13 |
2025-03-13 |
Corcept Therapeutics Inc |
Metodo para diagnosticar de manera diferencial el sindrome de cushing dependiente de la corticotropina.
|
|
AU2017228329B2
(en)
*
|
2016-03-01 |
2021-03-11 |
Corcept Therapeutics, Inc. |
The use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
|
|
US9943505B2
(en)
|
2016-09-09 |
2018-04-17 |
Corcept Therapeutics, Inc. |
Glucocorticoid receptor modulators to treat pancreatic cancer
|
|
PH12017000049B1
(en)
|
2017-02-20 |
2018-08-29 |
Peter S Heilveil |
Aerial cable spacer
|
|
AU2018244928B2
(en)
|
2017-03-31 |
2023-10-19 |
Corcept Therapeutics, Inc. |
Glucocorticoid receptor modulators to treat cervical cancer
|
|
CN113194931B
(zh)
|
2018-12-19 |
2023-11-10 |
科塞普特治疗公司 |
含有瑞拉可兰、杂芳基-酮稠合的氮杂十氢化萘化合物的药物制剂
|
|
NZ778399A
(en)
*
|
2019-02-22 |
2024-11-29 |
Corcept Therapeutics Inc |
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
|
|
AU2020239920A1
(en)
|
2019-03-18 |
2021-11-04 |
Arnold L. Newman |
Method of improving insulin sensitivity
|
|
JP2023515781A
(ja)
|
2020-02-10 |
2023-04-14 |
コーセプト セラピューティクス, インコーポレイテッド |
選択的グルココルチコイド受容体モジュレーターを使用して抗腫瘍応答を刺激する方法
|
|
WO2022134033A1
(en)
|
2020-12-25 |
2022-06-30 |
Corcept Therapeutics Incorporated |
Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
AU2023301396A1
(en)
|
2022-06-28 |
2024-12-12 |
Corcept Therapeutics Incorporated |
Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
WO2024077169A1
(en)
|
2022-10-06 |
2024-04-11 |
Corcept Therapeutics Incorporated |
Formulations of glucocorticoid receptor modulators
|